HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models.
Ke H, Zhang F, Wang J, Xiong L, An X, Tu X, Chen C, Wang Y, Mao B, Guo S, Ju C, He X, Sun R, Zhang L, O'Connor OA, Li QX.
Ke H, et al. Among authors: wang j, wang y.
Sci Rep. 2023 Apr 3;13(1):5419. doi: 10.1038/s41598-023-32547-y.
Sci Rep. 2023.
PMID: 37012357
Free PMC article.